Post by PLU Ophthalmic
751 followers
For decades, glaucoma surgeons have had to choose between two imperfect options. MIGS: minimal risk, but limited IOP reduction in moderate-to-advanced disease. Trabeculectomy: effective, but surgically complex with high postoperative burden. There was always a gap between them. AquaLumen™ was built to close it. Implant-free. Conjunctiva-sparing. Filtration-level IOP control — through a standardized ab externo approach that changes where subconjunctival filtration fits in the treatment algorithm. 🎯 Watch to see how it works. 🔗 Full white paper at Aqualumen.net | Link in bio #AquaLumen #GlaucomaSurgery #Ophthalmology #MedTech #GlaucomaInnovation #SubconjunctivalFiltration #ImplantFree #MIGS #GlaucomaCare
Video Content